معرفی
Lei Yang is an Associate Research Scientist at the Yale School of Medicine, affiliated with the Chen Liu Lab in the Department of Pathology. His academic journey began with a PhD in Molecular Biology from Jilin University, followed by postdoctoral training at Yale.
Lei's research focuses on cancer immunotherapies, particularly CAR-NK cell therapy and the development of tumor vaccines. His recent publication in Nature Communications (2025) explores the chemical modulation of CYP3A4, a critical enzyme in drug metabolism, demonstrating his interdisciplinary approach bridging pharmacology and cancer research.
While no formal awards are listed, Lei contributes to translational research at Yale, leveraging expertise in molecular biology and biomedical data science. He is actively involved in the Pathology department's research initiatives and has no recorded advisees.
